Product Name :
Pacritinib (SB1518)
CAS No.:
937272-79-2
Purity :
> 97%
Shipping:
Shipped on dry ice.
Storage :
Powder: -20 °C, 3 years; 4 °C, 2 yearsIn solvent: -80 °C, 6 months; -20 °C, 1 month
SMILES:
C1CCN(C1)CCOC2=CC=C3NC4=NC=CC(=N4)C5=CC(=CC=C5)COC\C=C\COCC2=C3
Product Description :
Pacritinib (SB1518) is a potent and selective inhibitor of Janus Kinase 2 (JAK2) and Fms-Like Tyrosine Kinase-3 (FLT3) with IC50s of 23 and 22 nM in cell-free assays, respectively.{{Upadacitinib} web|{Upadacitinib} Protein Tyrosine Kinase/RTK|{Upadacitinib} Purity & Documentation|{Upadacitinib} References|{Upadacitinib} manufacturer|{Upadacitinib} Autophagy} Phase 3.{{Nemolizumab} web|{Nemolizumab} Interleukin Related|{Nemolizumab} Biological Activity|{Nemolizumab} In Vivo|{Nemolizumab} custom synthesis|{Nemolizumab} Autophagy}
Formula:
C28H32N4O3
Molecular Weight :
472.58
Synonyms:
Additional Information:
|CAS No. 937272-79-2 ; |Formula C28H32N4O3 ; |Molecular Weight 472.58 ; |SMILES C1CCN(C1)CCOC2=CC=C3NC4=NC=CC(=N4)C5=CC(=CC=C5)COC\C=C\COCC2=C3 ; |Product Description Pacritinib (SB1518) is a potent and selective inhibitor of Janus Kinase 2 (JAK2) and Fms-Like Tyrosine Kinase-3 (FLT3) with IC50s of 23 and 22 nM in cell-free assays, respectively.PMID:23865629 Phase 3. ; |Purity > 97% ; |Shipping Shipped on dry ice. ; |Storage Powder: -20 °C, 3 years; 4 °C, 2 yearsIn solvent: -80 °C, 6 months; -20 °C, 1 month ; |Solubility Overview Soluble in DMSO